Crescent Biopharma CBIO
NASDAQ CBIO
$14.32 +0.06 (+0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Change in Intangibles (2026)

Updated

Crescent Biopharma (CBIO) recorded Change in Intangibles of $8 million in Q1 2026.

Analysis

Crescent Biopharma (CBIO) Change in Intangibles (2026) Analysis & Trends

For FY2025, Crescent Biopharma reported Change in Intangibles of $72 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -437.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.34 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Crescent Biopharma 397.47 Mn -309.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 8.00 Mn
API Access

Crescent Biopharma Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=CBIO&period=max&api_key=YOUR_API_KEY